Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q4 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• Hyperscale Data launches $300M at-the-market stock offering